ImmunityBio, Inc. (IBRX)
NASDAQ·Healthcare·Biotechnology
$7.14
-0.83%
Mkt Cap $7.59B
Analyst Ratings
Buy
23
Hold
0
Sell
0
Price Target (5 analysts)
$13.50
Range $12.00 – $15.00
Implied Upside
+89.1%
Consensus $13.50 vs current $7.14
NASDAQ·Healthcare·Biotechnology
$7.14
-0.83%
Mkt Cap $7.59B
Buy
23
Hold
0
Sell
0
Price Target (5 analysts)
$13.50
Range $12.00 – $15.00
+89.1%
Consensus $13.50 vs current $7.14